Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Susan H Alexander is EVP Chief Legal Officer at Biogen. OQRO lists 10 transactions filed with the SEC under this name, the latest on Feb 18, 2026, each linked to the official Form 4.
EVP Chief Legal Officer
Disclosures on record
10
Companies involved
1
Susan H Alexander has no open-market purchase on record since 2008. Sales in 5 of the 19 years since 2008.
Susan H Alexander reported 0 open-market purchases and 23 sales since 2008; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2022 | — | $1.55M1×1 trade |
| 2017 | — | $3.65M2×2 trades |
| 2012 | — | $22.2M11×11 trades |
| 2011 | — | $2.16M7×7 trades |
| 2008 | — | $656K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
BiogenBIIB
10 disclosures · Feb 2026
Feb 13, 20268,450disclosed Feb 18
DetailsOfficial recordFeb 6, 20262,190disclosed Feb 10
DetailsOfficial recordFeb 6, 20261,940disclosed Feb 10
DetailsOfficial recordFeb 6, 20264,916disclosed Feb 10
DetailsOfficial recordFeb 6, 20264,916disclosed Feb 10
DetailsOfficial recordFeb 6, 20262,190disclosed Feb 10
DetailsOfficial recordFeb 6, 20261,940disclosed Feb 10
DetailsOfficial recordFeb 6, 2026931disclosed Feb 10
DetailsOfficial recordFeb 6, 20261,059disclosed Feb 10
DetailsOfficial recordFeb 6, 20261,514disclosed Feb 10
DetailsOfficial recordAs of the latest filing on , Susan H Alexander reported holding 41,807 shares of Biogen (BIIB), worth about $10.5M at the last close of $251 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Biogen BIIB | 41,807 | 42K direct | $251 | $10.5M | Feb 6, 2026 |
Is this Susan H Alexander’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Feb 6, 2026, Susan H Alexander reported holding 41,807 shares of Biogen (BIIB). At the last close of $251 on Nov 18, 2026, that is about $10.5M. This is the stake disclosed in filings, not a net worth.
No public filing gives Susan H Alexander's net worth. What SEC Form 4 shows is the stock stake: 41,807 shares of Biogen (BIIB), about $10.5M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Susan H Alexander has no open-market purchase on record since 2008. Sales in 5 of the 19 years since 2008.
In SEC filings since 2008: no open-market purchase is on record; the latest open-market sale is from 2022.
Biogen (BIIB), from 2008 to 2022: 0 purchases and 23 sales.
Susan H Alexander reported 0 open-market purchases and 23 sales here, 2008 to 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.